Related references
Note: Only part of the references are listed.The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats
Giulia Costa et al.
NEUROPHARMACOLOGY (2019)
The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models
Francesco Napolitano et al.
NEUROSCIENCE (2018)
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity
Giulia Costa et al.
NEUROTOXICITY RESEARCH (2018)
Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age
Giulia Costa et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Sex Differences in Neurotoxicogenetics
Carolina Torres-Rojas et al.
FRONTIERS IN GENETICS (2018)
Acute MDMA and Nicotine Co-administration: Behavioral Effects and Oxidative Stress Processes in Mice
Barbara Budzynska et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)
Persistent Psychosis due to Single Dose of Ecstasy
Sanya Virani et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2018)
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage
Giulia Costa et al.
NEUROTOXICITY RESEARCH (2017)
Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques
Francesco Napolitano et al.
PLOS ONE (2017)
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
Rosario Moratalla et al.
PROGRESS IN NEUROBIOLOGY (2017)
Brain microglia in psychiatric disorders
Valeria Mondelli et al.
LANCET PSYCHIATRY (2017)
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent
Lucia Frau et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice
Daniela Vitucci et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging
Annalisa Pinna et al.
MOVEMENT DISORDERS (2016)
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain
Lucia Frau et al.
NEUROTOXICOLOGY (2016)
In vivo imaging of neuroinflammation in schizophrenia
Ofer Pasternak et al.
SCHIZOPHRENIA RESEARCH (2016)
RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network (Rhesactome) in the striatum
Neelam Shahani et al.
SCIENCE SIGNALING (2016)
RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network (Rhesactome) in the striatum
Neelam Shahani et al.
SCIENCE SIGNALING (2016)
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons
Giuseppe Sciamanna et al.
NEUROBIOLOGY OF DISEASE (2015)
THE ROLE OF INFLAMMATION AND MICROGLIAL ACTIVATION IN THE PATHOPHYSIOLOGY OF PSYCHIATRIC DISORDERS
G. Z. Reus et al.
NEUROSCIENCE (2015)
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion
Veronica Ghiglieri et al.
SCIENTIFIC REPORTS (2015)
Rhes, a Striatal-selective Protein Implicated in Huntington Disease, Binds Beclin-1 and Activates Autophagy
Robert G. Mealer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine
Laura E. Halpin et al.
LIFE SCIENCES (2014)
Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining
Sara Ares-Santos et al.
NEUROPSYCHOPHARMACOLOGY (2014)
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex
Giulia Costa et al.
PSYCHOPHARMACOLOGY (2014)
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility
Lucia Frau et al.
JOURNAL OF NEUROCHEMISTRY (2013)
MPTP-Induced Dopamine Neuron Degeneration and Glia Activation Is Potentiated in MDMA-Pretreated Mice
Giulia Costa et al.
MOVEMENT DISORDERS (2013)
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson's disease
Juliet M. Taylor et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Rhes: A GTP-Binding Protein Integral to Striatal Physiology and Pathology
Laura M. Harrison
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia
Srinivasa Subramaniam et al.
NATURE NEUROSCIENCE (2012)
Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease
Serge Maia et al.
SYNAPSE (2012)
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
Noelia Granado et al.
NEUROBIOLOGY OF DISEASE (2011)
Mice lacking rhes show altered morphine analgesia, tolerance, and dependence
Franklin A. Lee et al.
NEUROSCIENCE LETTERS (2011)
Neurodegeneration and Inflammation in Parkinson's disease
Sudarshan Phani et al.
PARKINSONISM & RELATED DISORDERS (2011)
Exploration of sex differences in Rhes effects in dopamine mediated behaviors
Gabriel C. Quintero et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2011)
DISC1 Regulates New Neuron Development in the Adult Brain via Modulation of AKT-mTOR Signaling through KIAA1212
Ju Young Kim et al.
NEURON (2009)
The monomeric G proteins AGS1 and Rhes selectively influence Gαi-dependent signaling to modulate N-type (CaV2.2) calcium channels
Ashish Thapliyal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
RASD2, MYH9, and CACNG2 Genes at Chromosome 22q12 Associated with the Subgroup of Schizophrenia with Non-Deficit in Sustained Attention and Executive Function
Yu-Li Liu et al.
BIOLOGICAL PSYCHIATRY (2008)
Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice
Noelia Granado et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons
Francesco Errico et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Y. Yasuda et al.
BRAIN RESEARCH (2007)
Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms
Jean Lud Cadet et al.
NEUROTOXICITY RESEARCH (2007)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function
MI Colado et al.
PSYCHOPHARMACOLOGY (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
AR Green et al.
PHARMACOLOGICAL REVIEWS (2003)
Selective microglial activation in the rat rotenone model of Parkinson's disease
TB Sherer et al.
NEUROSCIENCE LETTERS (2003)
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (ecstasy) and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice
WE Fantegrossi et al.
PSYCHOPHARMACOLOGY (2003)
Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: Relevance to the etiology of Parkinson's disease
HM Gao et al.
JOURNAL OF NEUROSCIENCE (2003)
Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum
J Camarero et al.
JOURNAL OF NEUROCHEMISTRY (2002)
A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain
MI Colado et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
